Implementing an arts-based intervention for patients with end-stage kidney disease whilst receiving haemodialysis: a feasibility study protocol.
Art
Feasibility studies
Kidney failure, chronic
Randomised controlled trials as topic
Renal dialysis
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
2019
2019
Historique:
received:
21
08
2018
accepted:
19
12
2018
entrez:
10
1
2019
pubmed:
10
1
2019
medline:
10
1
2019
Statut:
epublish
Résumé
End-stage kidney disease is a life-changing illness. Many patients require haemodialysis, a treatment that impacts profoundly on quality of life and mental health. Arts-based interventions have been used in other healthcare settings to improve mental health and quality of life; therefore, they may help address the impact of haemodialysis by improving these outcomes. However, there is a lack of evidence assessing their effectiveness in this population and few randomised controlled trials (RCTs) evaluating the effectiveness of complex arts-based interventions. The aims of this study are to establish the feasibility of a cluster RCT of an arts-based intervention for patients with end-stage kidney disease whilst receiving haemodialysis through a cluster randomised pilot study, explore the acceptability of the intervention with a process evaluation and explore the feasibility of an economic evaluation. The study will have three phases. The first phase consists of a cluster randomised pilot study to establish recruitment, participation and retention rates. This will involve the recruitment of 30 participants who will be randomly allocated through cluster randomisation according to shift pattern to experimental and control group. The second phase will be a qualitative process evaluation to establish the acceptability of the intervention within a clinical setting. This will involve semi-structured interviews with 13 patients and three focus groups with healthcare professionals. The third phase will be a feasibility economic evaluation to establish the best methods for data collection within a future cluster RCT. Arts-based interventions have been shown to improve quality of life in healthcare settings, but there is a lack of evidence evaluating arts-based interventions for patients receiving haemodialysis. This study aims to assess the feasibility of a future cluster RCT assessing the impact of an arts-based intervention on the wellbeing and mental health of patients receiving haemodialysis and identify the key factors leading to successful implementation. The hope is this study will inform a trial that can influence future healthcare policy by providing robust evidence for arts-based interventions within the haemodialysis setting. The trial was prospectively registered on clinicaltrials.gov on 14/8/2018, registration number NCT03629496.
Sections du résumé
BACKGROUND
BACKGROUND
End-stage kidney disease is a life-changing illness. Many patients require haemodialysis, a treatment that impacts profoundly on quality of life and mental health. Arts-based interventions have been used in other healthcare settings to improve mental health and quality of life; therefore, they may help address the impact of haemodialysis by improving these outcomes. However, there is a lack of evidence assessing their effectiveness in this population and few randomised controlled trials (RCTs) evaluating the effectiveness of complex arts-based interventions.
METHODS
METHODS
The aims of this study are to establish the feasibility of a cluster RCT of an arts-based intervention for patients with end-stage kidney disease whilst receiving haemodialysis through a cluster randomised pilot study, explore the acceptability of the intervention with a process evaluation and explore the feasibility of an economic evaluation. The study will have three phases. The first phase consists of a cluster randomised pilot study to establish recruitment, participation and retention rates. This will involve the recruitment of 30 participants who will be randomly allocated through cluster randomisation according to shift pattern to experimental and control group. The second phase will be a qualitative process evaluation to establish the acceptability of the intervention within a clinical setting. This will involve semi-structured interviews with 13 patients and three focus groups with healthcare professionals. The third phase will be a feasibility economic evaluation to establish the best methods for data collection within a future cluster RCT.
DISCUSSION
CONCLUSIONS
Arts-based interventions have been shown to improve quality of life in healthcare settings, but there is a lack of evidence evaluating arts-based interventions for patients receiving haemodialysis. This study aims to assess the feasibility of a future cluster RCT assessing the impact of an arts-based intervention on the wellbeing and mental health of patients receiving haemodialysis and identify the key factors leading to successful implementation. The hope is this study will inform a trial that can influence future healthcare policy by providing robust evidence for arts-based interventions within the haemodialysis setting.
TRIAL REGISTRATION
BACKGROUND
The trial was prospectively registered on clinicaltrials.gov on 14/8/2018, registration number NCT03629496.
Identifiants
pubmed: 30622728
doi: 10.1186/s40814-018-0389-y
pii: 389
pmc: PMC6320589
doi:
Banques de données
ClinicalTrials.gov
['NCT03629496']
Types de publication
Journal Article
Langues
eng
Pagination
1Subventions
Organisme : Medical Research Council
ID : G0901530
Pays : United Kingdom
Déclaration de conflit d'intérêts
The author CC is a current PhD student at Queen’s University Belfast in Northern Ireland and will be undertaking this study as their PhD project, while HN, JR and IW are members of their supervisory team. Consequently the recruitment, implementation of the intervention, data collection for the cluster randomised pilot study, economic evaluation and process evaluation, and analysis of collected data, will all be completed by CC. Ideally these roles would be performed by different people or research teams to prevent introduction of bias, such as the halo effect, but the constraints of a PhD project do not allow this.This study has obtained ethical approval from the Office of Research Ethics Committees Northern Ireland (Ref: 18/NI/0091). An informed consent form will be signed by patients participating in the cluster randomised pilot study and parallel feasibility economic evaluation. A separate consent form will also be signed by patients and healthcare staff who participate in the parallel process evaluation.Not applicableThe authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Références
BMJ Open. 2017 Feb 17;7(2):e013537
pubmed: 28213598
J Clin Nurs. 2017 Sep;26(17-18):2545-2557
pubmed: 27862490
Value Health. 2013 Jan-Feb;16(1):195-201
pubmed: 23337231
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 27195450
Arts Health. 2015 Jan 2;7(1):27-41
pubmed: 25544861
Br J Clin Psychol. 2010 Nov;49(Pt 4):507-16
pubmed: 20021730
Pilot Feasibility Stud. 2016 Nov 29;2:70
pubmed: 27965885
J Clin Epidemiol. 2012 Mar;65(3):301-8
pubmed: 22169081
Trials. 2013 Oct 25;14:353
pubmed: 24160371
J Hum Reprod Sci. 2011 Jan;4(1):8-11
pubmed: 21772732
Pilot Feasibility Stud. 2016 Mar 15;2:17
pubmed: 27965837
J Pain Symptom Manage. 2014 Dec;48(6):1021-30
pubmed: 24863152
J Clin Epidemiol. 2014 Aug;67(8):912-20
pubmed: 24811157
Psychol Health. 2010 Dec;25(10):1229-45
pubmed: 20204937
Health Soc Care Community. 2018 Jul;26(4):458-473
pubmed: 28940775
J Psychiatr Ment Health Nurs. 2011 Aug;18(6):501-9
pubmed: 21749556
Braz J Psychiatry. 2016 Oct-Dec;38(4):301-306
pubmed: 26870913
BMC Nephrol. 2015 Sep 21;16:155
pubmed: 26390864
J Holist Nurs. 2018 Dec;36(4):341-353
pubmed: 28836473
Patient. 2011;4(1):19-30
pubmed: 21766891
Ir Med J. 2017 Sep 18;110(9):632
pubmed: 29372947
Int J Nurs Pract. 2015 Feb;21(1):1-10
pubmed: 24124912
J Palliat Med. 2017 Oct;20(10):1127-1134
pubmed: 28537462
BMC Med Res Methodol. 2010 Jul 16;10:67
pubmed: 20637084
Int J Nurs Stud. 2010 Nov;47(11):1354-62
pubmed: 20403600
Nephrology (Carlton). 2017 Mar;22(3):228-233
pubmed: 26891151
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Asian J Psychiatr. 2015 Dec;18:49-52
pubmed: 26549864
Saudi J Kidney Dis Transpl. 2016 Mar;27(2):331-4
pubmed: 26997387
Am J Orthopsychiatry. 1983 Oct;53(4):602-18
pubmed: 6638153
Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2250-2255
pubmed: 27660303
Arts Health. 2020 Feb;12(1):1-22
pubmed: 31038422
Arch Intern Med. 2000 Jun 26;160(12):1818-23
pubmed: 10871976
J Adv Nurs. 2000 Nov;32(5):1132-42
pubmed: 11114998
Am J Kidney Dis. 2011 Sep;58(3):335-7
pubmed: 21856491
Lancet. 2002 Mar 2;359(9308):781-5
pubmed: 11888606
Complement Ther Clin Pract. 2017 Nov;29:53-57
pubmed: 29122269
Clin J Am Soc Nephrol. 2008 Nov;3(6):1752-8
pubmed: 18684897
Biol Res Nurs. 2012 Jul;14(3):277-85
pubmed: 21708894
J Pain Symptom Manage. 2015 Dec;50(6):778-85
pubmed: 26300026
J Eval Clin Pract. 2004 May;10(2):307-12
pubmed: 15189396
Clin J Am Soc Nephrol. 2007 Nov;2(6):1332-42
pubmed: 17942763
BMC Med Res Methodol. 2011 Mar 11;11:26
pubmed: 21396104
J Ren Care. 2017 Mar;43(1):60-66
pubmed: 28000424
J Health Psychol. 2008 Oct;13(7):912-20
pubmed: 18809642
Int J Psychiatry Med. 2013;46(1):85-108
pubmed: 24547611
Prev Med Rep. 2017 Apr 04;6:322-328
pubmed: 28451518
Pilot Feasibility Stud. 2015 Sep 7;1:32
pubmed: 27965810
Iran J Kidney Dis. 2014 Nov;8(6):467-74
pubmed: 25362222
BMC Nephrol. 2016 Apr 27;17(1):44
pubmed: 27117687
Nephrol Nurs J. 2015 Jul-Aug;42(4):339-47; quiz 348
pubmed: 26462307
Oncol Nurs Forum. 2012 Jul;39(4):E353-60
pubmed: 22750906
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
BMC Med Res Methodol. 2012 Nov 23;12:178
pubmed: 23176384
J Ren Care. 2014 Dec;40(4):249-56
pubmed: 24980265
Semin Dial. 2005 Mar-Apr;18(2):142-6
pubmed: 15771659
Health Technol Assess. 2014 Jun;18(38):1-197, v-vi
pubmed: 24914457
Int J Nephrol Renovasc Dis. 2018 Mar 12;11:93-102
pubmed: 29559806
Nefrologia. 2014;34(5):637-57
pubmed: 25259819
Arts Health. 2015 Jan 2;7(1):1-13
pubmed: 25544860
Trials. 2015 Apr 11;16:150
pubmed: 25872619
Int J Obes (Lond). 2009 Aug;33 Suppl 4:S60-7
pubmed: 19623191
Qual Life Res. 2016 Sep;25(9):2295-306
pubmed: 26941217
Ther Clin Risk Manag. 2017 Feb 23;13:263-272
pubmed: 28260913
Am J Kidney Dis. 2006 Mar;47(3):462-8
pubmed: 16490625
Am J Kidney Dis. 2003 Jan;41(1):105-10
pubmed: 12500227
Ann Oncol. 2011 Oct;22(10):2330-3
pubmed: 21339383
Am J Crit Care. 2007 May;16(3):222-35; quiz 236
pubmed: 17460313
PLoS One. 2016 Mar 15;11(3):e0150205
pubmed: 26978655
J Pain Symptom Manage. 2017 Apr;53(4):783-803.e1
pubmed: 28042060
Implement Sci. 2013 Feb 13;8:18
pubmed: 23406398
Int J Nurs Stud. 2016 Apr;56:90-101
pubmed: 26696399
Nephrol Dial Transplant. 2011 May;26(5):1628-34
pubmed: 20921294